Differential Effects of Predosing on Tumor and Tissue Uptake of an 111In-Labeled Anti-TENB2 Antibody

Differential Effects of Predosing on Tumor and Tissue Uptake of an 111In-Labeled Anti-TENB2 Antibody–Drug Conjugate

Published:2012-08-07 Issue:9 Volume:53 Page:1454-1461
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Boswell C. Andrew,Mundo Eduardo E.,Zhang Crystal,Stainton Shannon L.,Yu Shang-Fan,Lacap Jennifer A.,Mao Weiguang,Kozak Katherine R.,Fourie Aimee,Polakis Paul,Khawli Leslie A.,Lin Kedan

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference40 articles.

1. Arming antibodies: prospects and challenges for immunoconjugates

2. Targeted Cancer Therapy: Conferring Specificity to Cytotoxic Drugs

3. Antibody-Drug Conjugates for Cancer Therapy

4. A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus

5. Improved delivery of radiolabeled anti-B1 monoclonal antibody to Raji lymphoma xenografts by predosing with unlabeled anti-B1 monoclonal antibody;Buchsbaum;Cancer Res.,1992

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Somatostatin Receptor Subtype-2 Targeting System for Specific Delivery of Temozolomide;Journal of Medicinal Chemistry;2024-02-12

2. Bioanalytical Assays for Pharmacokinetic and Biodistribution Study of Antibody-Drug Conjugates;Drug Metabolism and Disposition;2023-06-08

3. Effect of molecular size on interstitial pharmacokinetics and tissue catabolism of antibodies;mAbs;2022-07-22

4. New Technologies Bloom Together for Bettering Cancer Drug Conjugates;Pharmacological Reviews;2022-06-16

5. Key metrics to expanding the pipeline of successful antibody–drug conjugates;Trends in Pharmacological Sciences;2021-10